Dry Eye News and Research

RSS
Dry eye is one of the most common complaints seen by eye doctors, accounting for nearly one fourth of all office visits. Caused by insufficient tear production or excessive tear evaporation, dry eye can be a mild, episodic feeling of discomfort associated with certain circumstances, such as exposure to dry, hot or windy environments; however, it can also be a chronic medical condition that, if left untreated, may lead to increased risk of infection or visual impairment.
FDA approves Parion’s investigational new drug application for treatment of dry eye disease

FDA approves Parion’s investigational new drug application for treatment of dry eye disease

Kala Pharmaceuticals completes $22.5 million Series B financing

Kala Pharmaceuticals completes $22.5 million Series B financing

New report reveals potential breakthrough in pterygium treatment

New report reveals potential breakthrough in pterygium treatment

SIFI, NovaMedica agree to market eight products for treatment of ophthalmic pathologies in Russia

SIFI, NovaMedica agree to market eight products for treatment of ophthalmic pathologies in Russia

Rigel Pharmaceuticals reports net loss of $16.9 million for fourth quarter 2013

Rigel Pharmaceuticals reports net loss of $16.9 million for fourth quarter 2013

Eleven Biotherapeutics announces first pivotal Phase 3 clinical study of EBI-005 for treatment of DED

Eleven Biotherapeutics announces first pivotal Phase 3 clinical study of EBI-005 for treatment of DED

ARIAD Pharmaceuticals' Iclusig now commercially available to patients in the U.S.

ARIAD Pharmaceuticals' Iclusig now commercially available to patients in the U.S.

CF101 drug fails to meet primary efficacy endpoint in phase III study for Dry Eye Syndrome

CF101 drug fails to meet primary efficacy endpoint in phase III study for Dry Eye Syndrome

Researchers identify potential therapy for meibomian gland dysfunction

Researchers identify potential therapy for meibomian gland dysfunction

Residents of major cities with high pollution levels have increased risk of dry eye syndrome

Residents of major cities with high pollution levels have increased risk of dry eye syndrome

Neuroptis Biotech reports positive results from ML7 preclinical trials for eye surface diseases

Neuroptis Biotech reports positive results from ML7 preclinical trials for eye surface diseases

Dry eye disease symptom change independent of tear osmolarity

Dry eye disease symptom change independent of tear osmolarity

Edimer doses first XLHED-affected neonate in Phase 2 trial of EDI200

Edimer doses first XLHED-affected neonate in Phase 2 trial of EDI200

Altaire Pharmaceuticals recalls 9 lots of Carboxymethylcellulose Sodium 0.5% Ophthalmic Solution

Altaire Pharmaceuticals recalls 9 lots of Carboxymethylcellulose Sodium 0.5% Ophthalmic Solution

Rigel plans to focus on completing three clinical programs for ITP, DLE and dry eye disease

Rigel plans to focus on completing three clinical programs for ITP, DLE and dry eye disease

Study: Daily dietary supplementation with blend of omega fatty acids improves severe dry eye

Study: Daily dietary supplementation with blend of omega fatty acids improves severe dry eye

Novaliq receives CE mark approval for EyeSol technology

Novaliq receives CE mark approval for EyeSol technology

Bausch + Lomb obtains option to license MIM-D3 for treatment of dry eye syndrome

Bausch + Lomb obtains option to license MIM-D3 for treatment of dry eye syndrome

Eleven Biotherapeutics reports positive results from EBI-005 Phase 1b/2a study in patients with DED

Eleven Biotherapeutics reports positive results from EBI-005 Phase 1b/2a study in patients with DED